Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

$24.99

Net Profit Margin
since 2005

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Abbott Laboratories, net profit margin, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in millions


The financial data reveals several noteworthy trends in net earnings, net sales, and net profit margin over the analyzed periods.

Net Earnings
Net earnings exhibit significant fluctuations across the years. There is an initial decline from 3372 million US$ in 2005 to a low of 1717 million US$ in 2006, followed by a recovery and general upward trend reaching a peak of 7071 million US$ in 2021. Following this high, a slight decrease occurs in 2022 and 2023 before a substantial increase to 13402 million US$ in 2024. The trend indicates periods of volatility but overall growth in profitability towards the end of the cycle.
Net Sales
Net sales generally show a positive growth trajectory from 22,338 million US$ in 2005 to 43,653 million US$ in 2022, almost doubling over this span. Some intermittent declines are visible, notably in 2013 and 2014, where sales fall sharply to around 20,000 million US$. After this decline, sales recover and peak in 2022, followed by a slight decrease in the last two years, ending at approximately 41,950 million US$ in 2024. The overall pattern reflects steady expansion with occasional contractions.
Net Profit Margin
The net profit margin percentage shows considerable variability, fluctuating between a low of 1.74% in 2017 and a high of 31.95% in 2024. Early years show margins in the range of 7.64% to 18.68%, indicating moderate profitability. Notably, there is a marked dip in profitability around 2016-2017, followed by a resurgence starting in 2018, culminating in a significant margin improvement in 2024. This suggests increasing efficiency or a more profitable product/service mix in the later years.

In summary, the financial performance metrics indicate a company experiencing cyclical revenue and earnings changes but demonstrating resilience and growth over the long term. The significant improvement in net profit margin towards the latest year implies enhanced operational effectiveness or strategic shifts yielding higher profitability.


Comparison to Competitors

Abbott Laboratories, net profit margin, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Health Care Equipment & Services)

Abbott Laboratories, net profit margin, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Industry (Health Care)